Memory Inhibition and Delayed Onset Post-traumatic Stress Disorder in Older Subjects
NCT ID: NCT03897855
Last Updated: 2021-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-04-01
2021-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This little-known pathology and notable psychiatric co-morbidities (depression, anxiety) can take in elderly subjects different masks that interfere with diagnosis and treatment.
The data in the literature suggest that this Post-Traumatic Stress Disorder with Delayed Expression (TSPT-R) may be related to a deficiency of the executive functions of inhibition, and more particularly a deficit of mental memory inhibition and therefore the removal of unwanted memories.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating
NCT00288314
Enhancing Memory in CPT for PTSD
NCT06000475
Post-traumatic Stress Disorder (PTSD) Symptoms in Later Life
NCT03821259
Stress and Emotional Memory
NCT02510755
Post Traumatic Stress Disorder and Neural Mechanisms Involved in Its Treatment
NCT00893568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient (TSPT-R)
Post Traumatic Stress Disorder
Post Traumatic Stress Disorder
The test "Think / No-Think"
control
No Post Traumatic Stress Disorder
Post Traumatic Stress Disorder
The test "Think / No-Think"
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Post Traumatic Stress Disorder
The test "Think / No-Think"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Regarding the constitution of the group patient (TSPT-R):
* Subjects 65 years of age or older
* Clinical diagnosis of delayed-onset PTSD according to DSM-5 criteria after 65 years
* The traumatic event must have taken place at the latest before 65 years
* Affiliated person or beneficiary of a social security scheme.
* Written consent before any examination required by research)
Regarding the constitution of the control group:
* Subjects 65 years of age or older
* No diagnosis of PTSD (delayed or not) or history of PTSD (delayed or not)
* Affiliated person or beneficiary of a social security scheme.
* Written consent before any examination required by the research).
Exclusion Criteria
* Acute or chronic cognitive impairment known
* GRECO MMSE pathological score less than or equal to the pathological threshold weighted according to level of education and age, namely:
* 22 if no diploma
* 23 if certificate of study
* 25 if patent
* 26 if bin or more
* Remove one point at each threshold if age\> 80 years
* Sensory or motor disorder preventing the passing of different tests
* Psychotic disorder
* Mood disorder in decompensation (for depression, HAD-D score equal to or greater than 11)
* Disorder of the use of a moderate or severe substance (except tobacco).
* Patients under guardianship or curatorship.
65 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Niort
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique LEGER, Doctor
Role: STUDY_DIRECTOR
Centre Hospitalier de Niort
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de Niort
Niort, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CH-NIORT-2018-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.